What Is the Legislative History Behind IRC Section 280E?
The story of Section 280E begins not with cannabis but with cocaine. In 1981, Jeffrey Edmondson, a convicted drug dealer operating in Minneapolis, filed a federal tax return for his drug trafficking operation and claimed deductions for ordinary business expenses including a telephone line, a scale, packaging materials, and rent on a safe house. The IRS denied the deductions, but the United States Tax Court ruled in Edmondson's favor in a 1981 memorandum decision, holding that under the existing tax code, a trade or business engaged in illegal activity was entitled to the same deductions as any other trade or business. The court's reasoning was straightforward: Section 162 of the Internal Revenue Code allowed a deduction for all ordinary and necessary expenses of carrying on a trade or business, and the statute contained no exception for illegal businesses.
Congress reacted swiftly. In 1982, the Tax Equity and Fiscal Responsibility Act (TEFRA) added Section 280E to the Internal Revenue Code. The provision is remarkably brief, consisting of a single sentence: "No deduction or credit shall be allowed for any amount paid or incurred during the taxable year in carrying on any trade or business if such trade or business (or the activities which comprise such trade or business) consists of trafficking in controlled substances (within the meaning of schedule I and II of the Controlled Substances Act) which is prohibited by Federal law or the law of any State in which such trade or business is conducted." The legislative history confirms that Congress intended the provision to apply broadly to any business whose activities involve trafficking in Schedule I or Schedule II controlled substances.
At the time of enactment, the provision was directed at black-market drug operations. The legal cannabis industry did not exist. California did not pass the Compassionate Use Act (the nation's first medical marijuana law) until 1996, and Colorado and Washington did not legalize recreational cannabis until 2012. The application of a 1982 anti-drug-trafficker provision to state-licensed, regulated cannabis businesses generating billions in tax revenue was never contemplated by the legislators who drafted it. Yet because marijuana remains classified as a Schedule I controlled substance under the Controlled Substances Act, Section 280E applies with full force to every cannabis cultivator, manufacturer, distributor, and retailer in the country.
The Controlled Substances Act classification is the linchpin. Schedule I substances are defined as having a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. The DEA has maintained marijuana's Schedule I classification despite extensive state-level legalization and growing scientific evidence of medical applications. Multiple petitions to reschedule marijuana have been filed and denied over the decades, though the most recent review, initiated in 2022 at the direction of President Biden, represents the most serious reconsideration of marijuana's scheduling in the history of the CSA.
What Did the CHAMP Decision Establish for Cannabis Tax Law?
The CHAMP case (Californians Helping to Alleviate Medical Problems, Inc. v. Commissioner, 128 T.C. No. 14, 2007) is the most important Tax Court decision for cannabis businesses seeking to mitigate the impact of 280E. CHAMP was a San Francisco nonprofit that operated a medical cannabis dispensary alongside a separate set of programs providing counseling, food, and social services to its members. The IRS argued that CHAMP was engaged exclusively in trafficking in a controlled substance and therefore all of its expenses were disallowed under 280E.
The Tax Court disagreed. Judge Laro held that CHAMP operated two distinct activities: cannabis distribution and caregiving services. Because the caregiving services were not themselves trafficking in a controlled substance, the expenses attributable to those services were deductible under the normal rules of Section 162. The court required CHAMP to allocate its expenses between the two activities using a reasonable method and allowed deductions only for the non-cannabis portion.
The practical significance of CHAMP cannot be overstated. Before this decision, many cannabis businesses assumed that 280E eliminated all deductions without exception. CHAMP established the principle that a business entity can conduct both cannabis and non-cannabis activities, and that 280E applies only to the cannabis portion. This created the legal foundation for the entity-splitting strategy that is now widely used in the industry: structuring operations so that a cannabis entity handles the plant-touching activities while a separate entity provides management services, real estate leasing, branding, consulting, or ancillary product sales. The expenses of the non-cannabis entity remain fully deductible.
The CHAMP principle has limitations. The IRS scrutinizes entity-splitting arrangements for economic substance. If the non-cannabis entity has no genuine business purpose beyond tax avoidance, or if the allocation of expenses between entities does not reflect the actual economics of the operations, the IRS will collapse the structure and apply 280E to the full amount. The arrangement must have a legitimate business rationale, the entities must be operated as genuinely separate businesses, and the transfer pricing between them must be at arm's length.
At Northstar, we implement CHAMP-based structures for cannabis clients by ensuring that the non-cannabis entity provides real, documented services at rates that comparable independent providers would charge. We maintain separate books, separate bank accounts, separate contracts, and separate payroll for each entity. The documentation standard we apply is that the structure should be defensible not just on paper but under the scrutiny of an IRS examiner who is specifically trained to challenge cannabis tax positions.
How Did the Olive and Harborside Cases Shape 280E Enforcement?
The Olive case (Olive v. Commissioner, 139 T.C. 19, 2012) addressed a question left partially open by CHAMP: how broadly can a cannabis business define its cost of goods sold? Martin Olive operated a medical cannabis dispensary in California and argued that various operating expenses, including the cost of maintaining his dispensary facilities, should be treated as part of COGS rather than as disallowed operating expenses under 280E. The Tax Court rejected this position, holding that COGS must be calculated under the applicable provisions of the Internal Revenue Code (primarily Section 471) and cannot be expanded by reclassifying operating expenses as inventory costs.
The Olive decision is significant because it drew a clear line between COGS and operating expenses for cannabis businesses. Before Olive, some cannabis operators were aggressively categorizing expenses like rent, utilities, and administrative salaries as COGS on the theory that everything was "part of the cost of producing and selling the product." The court made clear that COGS is limited to costs that are includable in inventory under Section 471: direct materials, direct labor attributable to production, and the allocable portion of indirect costs that qualify as costs of procuring, securing, and maintaining inventory. Rent on a retail dispensary floor is not COGS. Rent on a cultivation facility's grow room, to the extent it is allocable to production activities, may be.
The Harborside Health Center cases (Harborside Health Center, Inc. v. Commissioner, multiple proceedings from 2012 through 2018) involved one of the largest and most prominent medical cannabis dispensaries in the country. The IRS assessed approximately $2.4 million in additional taxes against Harborside for the 2007 and 2008 tax years, arguing that the dispensary had improperly deducted operating expenses that 280E disallowed. Harborside challenged the assessment, arguing among other things that the IRS's application of 280E to state-legal medical cannabis operations was unconstitutional and that Harborside's non-cannabis activities (health and wellness services) should be separated under the CHAMP principle.
The Tax Court ruled largely in the IRS's favor, denying Harborside's constitutional challenges and accepting the IRS's COGS calculations with only minor adjustments. The court's treatment of Harborside's non-cannabis activities was narrower than what CHAMP might have suggested, finding that the caregiving services were so intertwined with the cannabis dispensary operation that meaningful separation was not possible. This sent a message to the industry: the CHAMP principle is real, but the non-cannabis activities must be genuinely distinct, separately operated, and independently viable. Incidental non-cannabis services tacked onto a dispensary operation will not satisfy the standard.
What Does Current IRS Enforcement of 280E Look Like?
The IRS has made cannabis businesses a compliance priority, and the enforcement posture is significantly more aggressive than what businesses in other industries experience. Cannabis operations are audited at an estimated rate of 5% to 10% annually, compared to an overall audit rate for small businesses of approximately 0.5% to 1%. The IRS has dedicated examination teams trained specifically on cannabis tax issues, and these teams are familiar with the common structures, deduction strategies, and documentation weaknesses of the industry.
The typical 280E audit follows a predictable pattern. The examiner requests three to five years of tax returns, financial statements, general ledgers, bank statements, and supporting documentation. The initial focus is on the COGS calculation: what costs did the taxpayer include in COGS, and are those costs legitimately includable as costs of procuring, securing, and maintaining inventory under Section 471? The examiner will compare the taxpayer's COGS to industry benchmarks. A dispensary claiming that 65% of its revenue is COGS when the industry average for dispensaries is 40% to 50% will face immediate challenge.
The second focus is on entity structure. If the taxpayer operates through multiple entities, the examiner will evaluate whether the entities have economic substance, whether the allocation of expenses between entities reflects arm's-length pricing, and whether the non-cannabis entity is genuinely conducting non-cannabis activities. Examiners are trained to look for indicators of sham arrangements: entities that share the same physical space without formal lease agreements, management fee arrangements that are not supported by documented time records, and intercompany pricing that does not correspond to market rates.
Average audit assessments for cannabis businesses range from $100,000 to $2 million, depending on the size of the operation and the years under examination. These assessments include not only the additional tax resulting from disallowed deductions but also accuracy-related penalties of 20% (applied when the IRS determines that the taxpayer's position was not supported by substantial authority) and interest that accrues from the original due date of the return. A $500,000 tax assessment for the 2021 tax year, with a 20% penalty and interest accruing through 2025, can easily reach $750,000 to $850,000 by the time it is finally resolved.
The defense against an IRS audit is documentation, documentation, and documentation. Every COGS item must be supported by an invoice, a time record, or an allocation methodology with a written rationale. Every intercompany transaction must be documented with a contract, a market rate analysis, and evidence of actual performance. Every non-cannabis activity must be supported by records showing that the activity was genuinely conducted, separately managed, and independently valuable. The time to prepare this documentation is before the audit notice arrives, not after.
How Is COGS Calculated Under Section 471 for Cannabis Businesses?
The cost of goods sold deduction is the only mechanism available to cannabis businesses to reduce gross income, making its calculation the single most consequential tax decision for any cannabis operation. Under Section 471, the inventory cost rules require producers and resellers to include certain costs in inventory as costs of procuring, securing, and maintaining inventory. For cannabis businesses, the scope of includable costs depends on whether the operation is a producer (cultivator, manufacturer), a reseller (dispensary), or both.
For cultivators, costs includable in COGS under Section 471 include seeds and clones (direct materials), growing medium, soil amendments, and nutrients (direct materials), wages and benefits for employees directly involved in planting, tending, irrigating, harvesting, and trimming (direct labor), depreciation on cultivation equipment and grow lights, utilities (electricity, water, HVAC) allocated to cultivation areas based on square footage or metered usage, quality testing and lab analysis costs, rent or mortgage interest allocated to cultivation and processing areas, property taxes allocated to cultivation areas, and packaging materials and direct labor for packaging.
For manufacturers (extraction, edible production, concentrate processing), costs includable in COGS under Section 471 include raw cannabis material, extraction solvents and chemicals, direct labor for extraction, formulation, and production, equipment depreciation, allocated facility costs, quality control and compliance testing, and packaging.
For dispensaries (resellers), the includable cost is primarily the purchase price of the inventory plus direct costs of acquisition. Under Section 471, resellers must also include costs of procuring, securing, and maintaining inventory, which may encompass a portion of their storage, handling, and purchasing costs.
The difference between a basic COGS calculation and a fully optimized Section 471 allocation is substantial. A cultivator that includes only the purchase price of seeds, nutrients, and direct labor in COGS might report a COGS-to-revenue ratio of 30%. The same cultivator, with a properly documented Section 471 allocation that includes facility costs, utilities, equipment depreciation, quality testing, and allocated indirect labor, might report a COGS-to-revenue ratio of 50% to 60%. On $3 million in revenue, that 20-to-30-point increase in the COGS ratio reduces taxable income by $600,000 to $900,000, saving $126,000 to $189,000 in federal taxes alone at the 21% corporate rate.
What Would Rescheduling Marijuana Mean for 280E?
The potential rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act represents the most significant tax development for the cannabis industry since 280E was enacted. Section 280E, by its explicit text, applies only to businesses trafficking in Schedule I or Schedule II controlled substances. If marijuana is reclassified as a Schedule III substance, cannabis businesses would immediately become eligible to deduct ordinary business expenses under Section 162, just like every other legal business in the country.
The financial impact would be transformational. Consider a dispensary with $5 million in annual revenue, $2 million in COGS, and $2.2 million in operating expenses. Under current law with 280E, taxable income is $3 million (revenue minus COGS only), and federal tax at 21% is $630,000. The company's actual economic profit is $800,000, producing an effective federal tax rate of 78.75%. Under rescheduling, the company would deduct its $2.2 million in operating expenses, producing taxable income of $800,000 and federal tax of $168,000, an effective rate of 21%. The annual tax savings for this single company would be $462,000.
Across the industry, the aggregate impact of rescheduling is estimated at $3 billion to $5 billion in annual federal tax savings. This capital, currently consumed by an inflated tax burden, would be available for reinvestment in operations, employee compensation, facility improvements, research and development, and expansion. Many industry observers believe that the elimination of 280E would be the single most significant catalyst for industry maturation and consolidation.
However, rescheduling introduces its own complexities. Amended return opportunities would arise for tax years still within the statute of limitations (generally three years from the filing date, or two years from the date of payment, whichever is later). Cannabis businesses that have overpaid taxes under 280E could file amended returns to claim refunds for the deductions that were previously disallowed. The procedural and documentation requirements for these refund claims would be substantial, and businesses with incomplete records would be unable to substantiate their claims.
State conformity questions would emerge immediately. States that conform to the federal tax code would automatically allow deductions, but states that have their own cannabis tax provisions might not update their statutes in tandem. California, for example, conforms to the IRC with certain modifications, and its treatment of cannabis deductions post-rescheduling would depend on how the state legislature responds.
Transition-year accounting would require careful handling. The tax year in which rescheduling takes effect would involve a mid-year change in the deductibility of expenses, requiring proration or allocation of expenses between the pre-rescheduling and post-rescheduling periods. This transition will generate complex tax positions that require professional guidance.
What Planning Strategies Should Cannabis Businesses Implement Now?
Regardless of the timing or outcome of rescheduling, cannabis businesses should implement tax planning strategies that reduce the current 280E burden while positioning the business to capture the full benefit of any future regulatory change.
Optimize the Section 471 COGS allocation as the highest-priority action. Engage a cannabis-specialized CPA to review the current COGS calculation against a full Section 471 analysis. Most cannabis businesses that have not undergone this review are leaving 15% to 30% of their legitimate COGS deduction on the table, which translates directly into overpaid federal taxes.
Evaluate entity restructuring under the CHAMP framework. If the business conducts both cannabis and non-cannabis activities, determine whether separating those activities into distinct legal entities would produce meaningful tax savings. The analysis must account for the additional administrative cost of maintaining multiple entities, the regulatory requirements for ownership changes in cannabis-licensed entities, and the documentation burden of maintaining arm's-length intercompany transactions. For businesses with operating expenses exceeding $500,000 per year in non-cannabis-attributable categories, the savings typically justify the structure.
Maintain audit-ready documentation at all times. Do not wait for an audit notice to organize records. Every COGS item should be supported by an invoice or cost record. Every intercompany transaction should be documented with a contract and market rate analysis. Every non-cannabis activity should be supported by separate books, time records, and revenue documentation. The standard is that an IRS examiner should be able to verify every tax position from the documentation alone, without needing to interview personnel or reconstruct records.
Build a tax reserve into the financial plan. Cannabis businesses that do not reserve for their federal and state tax obligations are the ones that face cash crises at tax time. At Northstar, we recommend that cannabis operators set aside 35% to 45% of gross profit (after COGS) in a dedicated tax reserve account, funded monthly. This reserve covers estimated federal and state income taxes, excise taxes, and provides a buffer for potential audit assessments.
Stay informed on rescheduling developments and prepare for the transition. When rescheduling occurs, the businesses that capture the most value will be those with clean financial records, properly documented COGS calculations, and a CPA team ready to file amended returns and restructure their tax positions quickly. Businesses that discover upon rescheduling that their records are incomplete will miss refund opportunities and delay the transition to standard tax treatment.
The burden of 280E is real and severe, but it is not infinite. The legislative environment is shifting, the courts have established workable frameworks for mitigation, and the administrative tools for COGS optimization are well understood. Cannabis businesses that engage specialized tax professionals and implement disciplined planning strategies can reduce their effective tax burden by 15% to 35% under current law and be positioned to capture the full benefit of rescheduling when it occurs.